Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30502469 | 1.00 | CES2 (0.33) | CES2CES1CA1CA2CA4 | |
| SCHEMBL29460057 | 0.80 | ALDH1A1 (0.31) | CES2CES1 | |
| SCHEMBL6483871 | 0.80 | CES2 (0.31) | CES2CES1 | |
| SCHEMBL5347272 | 0.80 | CA2 (0.32) | CES2CES1CA2 | |
| SCHEMBL1090760 | 0.80 | HDAC1 (0.33) | — | |
| SCHEMBL23830110 | 0.80 | — | — | |
| SCHEMBL2557587 | 0.80 | ALDH1A1 (0.31) | CES2CES1 | |
| SCHEMBL29459984 | 0.80 | — | — | |
| SCHEMBL20296440 | 0.78 | ALDH1A1 (0.31) | CES2CES1 | |
| SCHEMBL29517741 | 0.78 | ALDH1A1 (0.31) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025006693-A1 | CANNABIDIOL-LIKE COMPOUNDS AND METHODS FOR THE SELECTIVE PREPARATION OF THE SAME | UNIVERSITY OF MISSISSIPPI (US) | 2025-01-02 | — | — | WO | claimed |
| US-20100197960-A1 | METHOD FOR THE ORGANOCATALYTIC ACTIVATION OF CARBOXYLIC ACIDS FOR CHEMICAL, REACTIONS USING ORTHOSUBSTITUTED ARYLBORONIC ACIDS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2010-08-05 | — | — | US | claimed |
| EP-2193134-A1 | METHOD FOR THE ORGANOCATALYTIC ACTIVATION OF CARBOXYLIC ACIDS FOR CHEMICAL REACTIONS USING ORTHOSUBSTITUTED ARYLBORONIC ACIDS | The Governors Of The University Of Alberta (CA) | 2010-06-09 | — | — | EP | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2009030022-A1 | METHOD FOR THE ORGANOCATALYTIC ACTIVATION OF CARBOXYLIC ACIDS FOR CHEMICAL REACTIONS USING ORTHOSUBSTITUTED ARYLBORONIC ACIDS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2009-03-12 | — | — | WO | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-12637438-B2 | Protoporphyrinogen oxidase inhibitors | ENKO CHEM, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260068883-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | ENKO CHEM, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| CN-120285294-A | Intelligent biological battery for regeneration of diabetic bone defect, and preparation method and application thereof | 苏州大学附属第一医院 | 2025-07-11 | — | — | CN | disclosed |
| US-12302900-B2 | Protoporphyrinogen oxidase inhibitors | ENKO CHEM, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-20250059185-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2025-02-20 | — | — | US | disclosed |
| WO-2025006693-A1 | CANNABIDIOL-LIKE COMPOUNDS AND METHODS FOR THE SELECTIVE PREPARATION OF THE SAME | UNIVERSITY OF MISSISSIPPI (US) | 2025-01-02 | — | — | WO | disclosed |
| EP-4448522-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2024-10-23 | — | — | EP | disclosed |
| EP-0968158-B1 | METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM | BASELL POLYOLEFINE GMBH (DE) | 2005-08-10 | — | — | EP | disclosed |
| US-20050033076-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2005-02-10 | — | — | US | disclosed |
| WO-2004094481-A2 | POLYMERIZATION OF I-BUTENE IN HYDROCARBON MEDIA USING BIS(BORANE)CO-INITIATORS | THE UNIVERSITY OF AKRON (US) | 2004-11-04 | — | — | WO | disclosed |
| CN-1474826-A | Light emitting device and display | ������������ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197960-A1 | METHOD FOR THE ORGANOCATALYTIC ACTIVATION OF CARBOXYLIC ACIDS FOR CHEMICAL, REACTIONS USING ORTHOSUBSTITUTED ARYLBORONIC ACIDS | AOC2, AOC3, OXER1 | CES2 170/4885CES1 86/4885CA1 403/4885 |
| US-12302900-B2 | Protoporphyrinogen oxidase inhibitors | PPOX, PNPO, PPIF | CES2 1121/4885CES1 683/4885CA1 973/4885 |
| US-20250059185-A1 | BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | MGLL, LIPC, PNLIP | CES2 34/4885CES1 36/4885CA1 4405/4885 |
| US-12637438-B2 | Protoporphyrinogen oxidase inhibitors | PPOX, CYP4X1, CBR3 | CES2 717/4885CES1 367/4885CA1 1168/4885 |
| US-20260068883-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | PPOX, CYC1, CBR3 | CES2 598/4885CES1 177/4885CA1 875/4885 |
| US-20050033076-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP2J2, IDH3A | CES2 1925/4885CES1 3217/4885CA1 3547/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | CES2 1961/4885CES1 2736/4885CA1 3105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.